APA (7th ed.) Citation

J, S., M, C., O, B., AM, K., P, R., S, L., . . . TS, D. (2020). Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study. British journal of cancer, 123(7), 1071. https://doi.org/10.1038/s41416-020-0979-3

Chicago Style (17th ed.) Citation

J, Simon, et al. "Survival in Patients with HR+/HER2- Metastatic Breast Cancer Treated with Initial Endocrine Therapy Versus Initial Chemotherapy. A French Population-based Study." British Journal of Cancer 123, no. 7 (2020): 1071. https://doi.org/10.1038/s41416-020-0979-3.

MLA (9th ed.) Citation

J, Simon, et al. "Survival in Patients with HR+/HER2- Metastatic Breast Cancer Treated with Initial Endocrine Therapy Versus Initial Chemotherapy. A French Population-based Study." British Journal of Cancer, vol. 123, no. 7, 2020, p. 1071, https://doi.org/10.1038/s41416-020-0979-3.